Trung Huynh
Stock Analyst at RBC Capital
(4.85)
# 404
Out of 5,010 analysts
322
Total ratings
77.2%
Success rate
22.3%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 14,500p | 12,428p | +16.67% | 17 | Sep 29, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | CHF 400.00 | CHF 349.30 | +14.51% | 16 | Sep 28, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $263.29 | +6.35% | 15 | Sep 21, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $64 | $62.86 | +1.81% | 28 | Sep 21, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,975p | 1,856p | +6.41% | 16 | Sep 21, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $287 | $267.57 | +7.26% | 7 | Sep 21, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,500 | $1,184.63 | +26.62% | 28 | Sep 21, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $150 | $149.28 | +0.48% | 25 | Sep 21, 2026 | |
| PFE Pfizer | Reiterated: Hold | $25 | $28.72 | -12.95% | 40 | Sep 21, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 120.00 | CHF 120.92 | -0.76% | 12 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €80.00 | €71.47 | +11.94% | 18 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $595 → $660 | $750.51 | -12.06% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $25 | $0.6254 | n/a | 4 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $140 | $115.63 | n/a | 10 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $326 → $317 | $423.64 | n/a | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.2 → $1 | $1.35 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $38 | $31.64 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.98 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $12 | $6.84 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.25 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €10.00 → €13.50 | €9.49 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 700.00 → CHF 580.00 | CHF 584.00 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €44.00 → €40.00 | €53.00 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €14.00 → €12.00 | €10.32 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €105.00 | €143.20 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €57.00 | €48.88 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $31 | $7.30 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €165.00 | €137.40 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $71 | $38.31 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.41 | $35.57 | n/a | 2 | Jun 25, 2020 |
AstraZeneca PLC
Sep 29, 2026
Reiterated: Buy
Price Target: 14,500p
Current: 12,428p
Upside: +16.67%
Roche Holding AG
Sep 28, 2026
Reiterated: Buy
Price Target: CHF 400.00
Current: CHF 349.30
Upside: +14.51%
AbbVie
Sep 21, 2026
Reiterated: Buy
Price Target: $280
Current: $263.29
Upside: +6.35%
Bristol-Myers Squibb Company
Sep 21, 2026
Reiterated: Hold
Price Target: $64
Current: $62.86
Upside: +1.81%
GSK plc
Sep 21, 2026
Reiterated: Hold
Price Target: 1,975p
Current: 1,856p
Upside: +6.41%
Johnson & Johnson
Sep 21, 2026
Reiterated: Buy
Price Target: $287
Current: $267.57
Upside: +7.26%
Eli Lilly and Company
Sep 21, 2026
Reiterated: Buy
Price Target: $1,500
Current: $1,184.63
Upside: +26.62%
Merck & Co.
Sep 21, 2026
Reiterated: Hold
Price Target: $150
Current: $149.28
Upside: +0.48%
Pfizer
Sep 21, 2026
Reiterated: Hold
Price Target: $25
Current: $28.72
Upside: -12.95%
Novartis AG
Sep 14, 2026
Reiterated: Hold
Price Target: CHF 120.00
Current: CHF 120.92
Upside: -0.76%
Sep 14, 2026
Reiterated: Hold
Price Target: €80.00
Current: €71.47
Upside: +11.94%
Nov 7, 2025
Reiterated: Hold
Price Target: $595 → $660
Current: $750.51
Upside: -12.06%
Aug 15, 2025
Reiterated: Buy
Price Target: $29 → $25
Current: $0.6254
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $133 → $140
Current: $115.63
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $326 → $317
Current: $423.64
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $1.2 → $1
Current: $1.35
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $44 → $38
Current: $31.64
Upside: n/a
Apr 1, 2025
Reiterated: Buy
Price Target: $10 → $7
Current: $1.98
Upside: n/a
Mar 29, 2025
Reiterated: Buy
Price Target: $13 → $12
Current: $6.84
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4
Current: $2.25
Upside: n/a
Aug 24, 2023
Reiterated: Hold
Price Target: €10.00 → €13.50
Current: €9.49
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 584.00
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: €44.00 → €40.00
Current: €53.00
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: €14.00 → €12.00
Current: €10.32
Upside: n/a
Apr 13, 2022
Reiterated: Hold
Price Target: €105.00
Current: €143.20
Upside: n/a
Dec 13, 2021
Reiterated: Hold
Price Target: €57.00
Current: €48.88
Upside: n/a
Aug 4, 2021
Reiterated: Buy
Price Target: $28 → $31
Current: $7.30
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: €165.00
Current: €137.40
Upside: n/a
Oct 12, 2020
Reiterated: Buy
Price Target: $55 → $71
Current: $38.31
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.41
Current: $35.57
Upside: n/a